New Issue: ABN Amro sells $1.46 million 9.5% Knock-In Reverse Exchangeables linked to Pfizer

By Jennifer Chiou

New York, Nov. 18 - ABN Amro Bank NV priced $1.46 million 9.5% Knock-In Reverse Exchangeable notes due Nov. 17, 2006 linked to Pfizer Inc. stock, according to a 424B3 filing with the Securities and Exchange Commission.

Issuer:	ABN Amro Bank NV
Issue:	Knock-In Reverse Exchangeable senior medium-term series A notes
Underlying stock:	Pfizer Inc.
Amount:	$1.46 million
Maturity:	Nov. 17, 2006
Coupon:	9.5%, payable quarterly
Price:	Par
Payout at maturity:	Par in cash if Pfizer stock never trades at the knock-in level of $17.80 or below, otherwise smaller of par in cash or 44.944 shares of Pfizer stock
Knock-in price:	$17.80, 80% of initial price
Exchange ratio:	44.944
Exchange price:	$22.25 (initial level of Pfizer stock)
Pricing date:	Nov. 14
Settlement date:	Nov. 17
Lead manager:	LaSalle Financial Services, Inc., ABN Amro Inc.
Distribution:	Off shelf

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.